Cite
MLA Citation
M. Toulmonde et al.. “460 BIP2 (Bergonié Institute profiling program) bringing molecular profiling into routine practice in order to match molecular alterations with drugs in early phase trials.” European journal of cancer, vol. 51, n.d., pp. S98–. http://access.bl.uk/ark:/81055/vdc_100030628020.0x000012